COVID-19 and therapeutic VR adoption, part 1 with Dr. Robert Louis


COVID-19 and therapeutic VR adoption, part 1 with Dr. Robert Louis

June 12, 2020
WP Engine Wordpress Hosting

COVID-19 and therapeutic VR adoption, part 1 with Dr. Robert Louis

VR researcher and advocate Dr. Robert Louis gives HIMSS Media insight on the current state of VR in healthcare, and how the virus has impacted his hospital’s rollout of the technology.

Digital health spectators have long eyed therapeutic virtual reality’s progression from an interesting research concept to an evidence-backed treatment for pain, phobias and other conditions. But with COVID-19 throwing a wrench into healthcare’s status quo, will the virtual technology be seen as a key resource, or as a novelty to be sidelined until things can return to normal?

In this episode, VR researcher and advocate Dr. Robert Louis, endowed chair and program director at the Pickup Family Neurosciences Institute, and director of XR Development at Hoag Memorial Hospital, joins host Jonah Comstock and MobiHealthNews Associate Editor Dave Muoio to discuss how his hospital’s VR initiatives have been affected by the pandemic. 

 (Editor’s note: Louis serves as an advisor for Cleanbox Technology, mentioned in this episode)

More related to this episode: 

In-depth: Despite some hiccups, COVID-19 is VR’s time to shine

XRHealth raises $7M to expand its VR telehealth platform 

Oxford VR puts patients with social anxiety into virtual scenarios with new program

Reimagining Brain Surgery (YouTube demo)


Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

Supporting Diversity in Healthtech Investment (Dr. Fiona Pathiraja) Diversity is an increasingly debated topic in startup investments, since founders of under-represented backgrounds may it be gender, race, age, and more too often experience inequality in opportunities.